Chemomab Therapeutics Ltd
NASDAQ:CMMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
B
|
Bechtle AG
XMUN:BC8
|
DE |
|
Silex Systems Ltd
ASX:SLX
|
AU |
|
Ajinomoto Co Inc
F:AJI
|
JP |
|
InsuraGuest Technologies Inc
XTSX:ISGI
|
CA |
|
M
|
Mitsubishi UFJ Financial Group Inc
XHAM:MFZ
|
JP |
|
K-Bro Linen Inc
TSX:KBL
|
CA |
|
J
|
JT Corp
KOSDAQ:089790
|
KR |
|
C
|
China Gas Holdings Ltd
XHAM:EBZ
|
HK |
|
C
|
Clean Harbors Inc
F:CH6
|
US |
|
G
|
Gadsden Properties Inc
OTC:GADS
|
US |
|
C
|
China Resources Land Ltd
XMUN:CHZ
|
HK |
|
A
|
Acceler8 Ventures PLC
LSE:AC8
|
JE |
|
Earths Energy Ltd
F:3290
|
AU |
|
C
|
Capitol Federal Financial Inc
F:CFW
|
US |
|
G
|
Genix Pharmaceuticals Corp
OTC:GENPF
|
CA |
|
KRBL Ltd
NSE:KRBL
|
IN |
|
H
|
Himax Technologies Inc
SWB:H6Q
|
TW |
|
S
|
Suncorp Group Ltd
F:SU4
|
AU |
|
Canuc Resources Corp
XTSX:CDA
|
CA |
|
L
|
Lichen China Ltd
NASDAQ:LICN
|
CN |
|
Silex Systems Ltd
OTC:SILXY
|
AU |
|
GS Holdings Ltd
SGX:43A
|
SG |
|
Parrot SA
PAR:PARRO
|
FR |
Bankruptcy Probability
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Chemomab Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
513.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
205.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
62.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Chemomab Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.